Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2000 Apr;91(4):446–450. doi: 10.1111/j.1349-7006.2000.tb00965.x

Biodistribution of Boron Concentration on Melanoma‐bearing Hamsters after Administration of p‐, m‐, o‐Boronophenylalanine

Junichi Hiratsuka 1,✉, Kazuo Yoshino 2, Hirohumi Kondoh 3, Yoshinari Imajo 1, Yutaka Mishima 3
PMCID: PMC5926464  PMID: 10804294

Abstract

Although p‐boronophenylalanine (p‐BPA), a boronate analogue of tyrosine, has proven to be one of the most successful compounds for boron neutron capture therapy (BNCT) of malignant melanoma, the selective uptake mechanism of this compound into melanoma cells is not well understood. Therefore, the relationship between the structure of BPA and its specific affinity to melanoma cells appears worthy of investigation. In the present study, m‐ and o‐boronophenylalanine (m‐ and o‐BPA) were administered to melanoma‐bearing hamsters and their uptake was measured. The time courses (0.5, 2.0, 4.0 and 48.0 h) of boron concentrations in melanoma, normal skin, and blood were determined in male Syrian (golden) hamsters bearing Greene's melanomas following a single intraperitoneal injection of either p‐, m‐ or o‐BPA (100 mg/kg of BPA·fructose in 1.0 ml of saline). The boron concentrations in these tissues were measured by inductively coupled plasma‐atomic emission spectrometry (ICP‐AES). In melanoma, the order of boron uptake was p‐ >m‐>o‐BPA at all time points, and the boron concentrations obtained with p‐BPA and m‐BPA resembled each other in that they had a peak at 2 h after administration and decreased with time. The melanoma/skin boron concentration ratio of p‐BPA had a peak at 4 h after administration and the ratio ranged between 7/1 and 8/1. On the other hand, m‐BPA and o‐BPA had a peak at 2 h and their ratios ranged between 4/1 and 5/1. The difference in the accumulations of p‐BPA and m‐BPA could be due to a difference in the property of p‐BPA as a tyrosine analogue for melanin synthesis. The accumulation of m‐BPA into melanoma might indicate the baseline level of metabolism‐related amino acid transport. Our experimental findings indicate that this melanin synthesis, or the structural analogy between the boron compound and tyrosine as a precursor of melanin, is an important factor in the increased accumulation of p‐BPA in melanoma cells.

Keywords: BNCT, Melanoma, p‐Boronophenylalanine, Structural isomers

Full Text

The Full Text of this article is available as a PDF (63.5 KB).

REFERENCES

  • 1. ) Gabel , D. , Fairchild , R. G. , Borner , H. G. and Larsson , B.The relative biological effectiveness in V 79 Chinese hamster cells of the neutron capture reaction in boron and nitrogen . Radiat. Res. , 98 , 307 – 316 ( 1984. . [PubMed] [Google Scholar]
  • 2. ) Hatanaka , H. and Nakagawa , Y.Clinical results of long surviving brain tumor patients who underwent boron neutron capture therapy . Int. J. Radiat. Oncol. Biol. Phys. , 28 , 1061 – 1066 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Nakagawa , Y. and Hatanaka , H.Recent study of boron neutron capture therapy for malignant brain tumor in Japan . In“Cancer Neutron Capture Therapy ,” ed. Mishima Y. pp. 717 – 724 ( 1996. ). Plenum Press; , New York . [Google Scholar]
  • 4. ) Mishima , Y. , Honda , C. , Ichihashi , M. , Obara , H. , Hiratsuka , J. , Fukuda , H. , Karashima , H. , Kobayashi , T. , Kanda , K. and Yoshino , K.Treatment of malignant melanoma by single neutron capture treatment with melanomaseeking 10B‐compound . Lancet August 12 , 388 – 389 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Busse , P. M. , Zamenhof , R. , Madoc‐Jones , H. , Solares , G. , Kiger , S. , Riley , K. , Chuang , C. , Rogers , G. and Harling , O.Clinical follow‐up of patients with melanoma of the extremity treated in a phase I boron neutron capture therapy protocol . In“Advances in Neutron Capture Therapy. Volume I ,” ed. Larsson B. , Crawford J. and Weinreich R. , pp. 60 – 64 ( 1997. ). Elsevier Science; , Amsterdam . [Google Scholar]
  • 6. ) Ueda , S. , Imahori , Y. , Ohmori , Y. , Yoshino , E. , Ono , K. , Kobayashi , T. , Takagaki , M. , Oda , Y. , Ido , T. and Mishima , Y.Positron emission tomography and boron neutron capture therapy system to the patient with malignant brain tumor: the first clinical trial using 10B‐BPA . In“Cancer Neutron Capture Therapy ,” ed. Mishima Y. , pp. 823 – 827 ( 1996. ). Plenum Press; , New York . [Google Scholar]
  • 7. ) Chanana , A. D. , Coderre , J. A. , Joel , D. D. and Slatkin , D. N.Protocol for BNCT of glioblastoma multiforme at Brookhaven: practical considerations . In“Advances in Neutron Capture Therapy. Volume II ,” ed. Larsson B. , Crawford J. and Weinreich R. , pp. 571 – 574 ( 1997. ). Elsevier Science; , Amsterdam . [Google Scholar]
  • 8. ) Mehta , S. C. and Lu , D. R.Targeted drug delivery for boron neutron capture therapy . Pharm. Res. , 13 , 344 – 351 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Snyder , H. R. , Reedy , A. J. and Lennarj , W. J.Synthesis of aromatic boric acid. Aldehyde boronic acid and a boronic acid analogue of tyrosine . J. Am. Chem. Soc. , 80 , 835 – 838 ( 1958. ). [Google Scholar]
  • 10. ) Tsuji , M. and Mishima , Y.Selective affinity of 101‐paraboronophenylalanine‐HCl to malignant melanoma: for thermal neutron capture therapy . Jpn. J. Dermatol. , 93 , 773 – 778 ( 1983. ). [PubMed] [Google Scholar]
  • 11. ) Coderre , J. A. , Glass , J. D. , Fairchild , R. G. , Micca , P. L. , Fand , I. and Joel , D. D.Selective delivery of boron by the melanin precursor analogue p‐boronophenylalanine to tumors other than melanoma . Cancer Res. , 50 , 138 – 141 ( 1990. ). [PubMed] [Google Scholar]
  • 12. ) Mallesch , J. , Hons , B. P. , Moore , De. , Allen , B. J. , McCarthy , W. H. , Jones , R. and Stering , W. A.The pharmacokinetics of p‐boronophenylalanine fructose in human patients with glioma and metastatic melanoma . Int. J. Radiat. Oncol. Biol. Phys. , 28 , 1183 – 1188 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Papaspyrou , M. , Feinendegen , L. E. and Miller‐Gartner , H. W.Preloading with L‐tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells . Cancer Res. , 54 , 6311 – 6314 ( 1994. ). [PubMed] [Google Scholar]
  • 14. ) Yoshino , K. , Watanabe , N. , Takahashi , H. , Watanabe , S. , Mori , Y. , Ichihashi , M. , Kakihana , H. and Mishima , Y.Chemical properties of p‐, m‐, o‐boronophenylalanine . In“Cancer Neutron Capture Therapy ,” ed. Mishima Y. , pp. 91 – 97 ( 1996. ). Plenum Press; , New York . [Google Scholar]
  • 15. ) Greene , H. S. N.A spontaneous melanoma in the hamster with a propensity for amelanotic alteration and sarcomatous transformation during transplantation . Cancer Res. , 18 , 422 – 425 ( 1958. ). [PubMed] [Google Scholar]
  • 16. ) Hiratsuka , J. , Kono , M. and Mishima , Y.RBEs of thermal neutron capture therapy and 10B(n, α)7Li reaction on melanoma‐ bearing hamster . Pigment Cell Res. , 2 , 352 – 355 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Yoshino , K. , Maruyama , T. , Takahashi , H. , Mori , Y. , Kakihana , H. and Mishima , Y.Synthesis of o‐ and m‐boronophenylalanine . In“Advances in Neutron Capture Therapy ,” ed. Soloway A. H. , Barth R. F. and Carpenter D. E. , pp. 261 – 264 ( 1993. ). Plenum Press; , New York . [Google Scholar]
  • 18. ) Yoshino , K. , Mori , K. , Kakihana , H. , Takahashi , H. , Mishima , Y. and Ichihashi , M.Chemical modeling with p‐boronophenylalanine for boron accumulation to and release from melanoma . In“Cancer Neutron Capture Therapy ,” ed. Mishima Y. , pp. 81 – 90 ( 1996. ). Plenum Press; , New York . [Google Scholar]
  • 19. ) Yoshino , K. , Mishima , Y. , Kimura , M. , Hiratsuka , J. , Mori , Y. , Ito , S. and Kakihana , H.Capture of p‐boronophenylalanine in malignant melanoma cells by complex formation with melanin monomers, DOPA, DHI and DHICA . In“Advances in Neutron Capture Therapy. Volume II ,” ed. Larsson B. , Crawford J. and Weinreich R. , pp. 234 – 238 ( 1997. ). Elsevier Science; , Amsterdam . [Google Scholar]
  • 20. ) Allen , B. J. , Corderoy‐Buck , S. , Mallesch , J. L. , Crotty , K. and Moor , D. E.Local control of SA melanoma xenografts in nude mice by neutron capture therapy . Melanoma Res. , 2 , 253 – 262 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Coderre , J. A.A phase one biodistribution study of p‐boronophenylalanine . In“Proceedings of an International Workshop and Plenary Meeting, Towards Clinical Trials of Glioma with BNCT, 18–20 September, 1992. Petten ,” pp. 111 – 121 ( 1992. ). Plenum Press; , the Netherlands . [Google Scholar]
  • 22. ) Matalka , K. Z. , Barth , R. F. , Staubus , A. E. , Moeschberger , M. L. and Coderre , J. A.Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent . Radiat. Res. , 137 , 44 – 51 ( 1994. ). [PubMed] [Google Scholar]
  • 23. ) Hiratsuka , J. , Yoshino , K. , Honda , C. , Mishima , Y. and Ichihashi , M.Tumor killing effect of BNCT after administration of o‐, m‐ and p‐boronophenylalanine . In“Advances in Neutron Capture Therapy. Volume II ,” ed. Larsson B. , Crawford J. and Weinreich R. , pp. 512 – 515 ( 1997. ). Elsevier Science; , Amsterdam . [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES